Skip to content
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Genmab
  4. Genmab — September 2023

Genmab — September 2023

Planlagt Fastgjort Låst Flyttet Genmab
781 Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • P Offline
    P Offline
    Pensionisten
    wrote on sidst redigeret af
    #688

    Måske en fat finger 😉

    1 Reply Last reply
    0
    • K Offline
      K Offline
      Klarussen
      wrote on sidst redigeret af
      #689

      Fuldstændig crazy kursforløb, hvad foregår der?

      1 Reply Last reply
      0
      • BulderB Offline
        BulderB Offline
        Bulder
        wrote on sidst redigeret af
        #690

        Der var kortvarigt voldsom omsætning

        1 Reply Last reply
        0
        • K Offline
          K Offline
          Klarussen
          wrote on sidst redigeret af
          #691

          Går amok (?!) Hvem ved noget?

          1 Reply Last reply
          0
          • BulderB Offline
            BulderB Offline
            Bulder
            wrote on sidst redigeret af
            #692

            Der må køre et rygte aften art

            1 Reply Last reply
            0
            • BulderB Offline
              BulderB Offline
              Bulder
              wrote on sidst redigeret af
              #693

              Voldgift?

              1 Reply Last reply
              0
              • P Offline
                P Offline
                Pensionisten
                wrote on sidst redigeret af
                #694

                Plejer at komme efter midnat fredag/lørdag

                1 Reply Last reply
                0
                • K Offline
                  K Offline
                  Klarussen
                  wrote on sidst redigeret af
                  #695

                  Nerverne sidder da vist lidt udenpå tøjet for nogen?

                  1 Reply Last reply
                  0
                  • FrittenF Offline
                    FrittenF Offline
                    Fritten
                    wrote on sidst redigeret af
                    #696

                    Jeg har større fornøjelse af at være i Genmab end at tage rutsjebanen i Tivoli:-)

                    1 Reply Last reply
                    0
                    • BulderB Offline
                      BulderB Offline
                      Bulder
                      wrote on sidst redigeret af
                      #697

                      Det der kan ikke være en tilfældig ting

                      1 Reply Last reply
                      0
                      • P Offline
                        P Offline
                        Pensionisten
                        wrote on sidst redigeret af
                        #698

                        Jeg har observeret, at der, generelt ofte sker mærkværdige ting hhv. kl. 13:30 og kl. 14.30

                        1 Reply Last reply
                        0
                        • E Offline
                          E Offline
                          E_L
                          wrote on sidst redigeret af
                          #699

                          Landmark Phase 3 MARIPOSA Study Meets Primary Endpoint Resulting in Statistically Significant and Clinically Meaningful Improvement in Progression-Free Survival for RYBREVANT® (amivantamab-vmjw) plus Lazertinib Versus Osimertinib in Patients with EGFR-Mutated Non-Small Cell Lung Cancer https://www.prnewswire.com/news-releases/landmark-phase-3-mariposa-study-meets-primary-endpoint-resulting-in-statistically-significant-and-clinically-meaningful-improvement-in-progression-free-survival-for-rybreva

                          1 Reply Last reply
                          0
                          • E Offline
                            E Offline
                            E_L
                            wrote on sidst redigeret af
                            #700

                            Planned interim overall survival analysis showed a trend favoring the combination of RYBREVANT® and lazertinib compared to osimertinib*

                            1 Reply Last reply
                            0
                            • E Offline
                              E Offline
                              E_L
                              wrote on sidst redigeret af
                              #701

                              First pivotal study to show a clinically meaningful benefit in a chemotherapy-free regimen versus osimertinib

                              1 Reply Last reply
                              0
                              • P Offline
                                P Offline
                                Pensionisten
                                wrote on sidst redigeret af
                                #702

                                Hvor finder du dog alle de godbidder, @EL? 😉

                                1 Reply Last reply
                                0
                                • BulderB Offline
                                  BulderB Offline
                                  Bulder
                                  wrote on sidst redigeret af
                                  #703

                                  Jamen så må det have været Mariposa data.

                                  1 Reply Last reply
                                  0
                                  • BulderB Offline
                                    BulderB Offline
                                    Bulder
                                    wrote on sidst redigeret af
                                    #704

                                    Jnj ligger stort set uændret i formarkedet.

                                    1 Reply Last reply
                                    0
                                    • BulderB Offline
                                      BulderB Offline
                                      Bulder
                                      wrote on sidst redigeret af
                                      #705

                                      Hvorfor skulle genmab stige på rybrevant og ikke jnj?

                                      1 Reply Last reply
                                      0
                                      • P Offline
                                        P Offline
                                        Pensionisten
                                        wrote on sidst redigeret af
                                        #706

                                        Det er da faktisk ret vildt ???

                                        1 Reply Last reply
                                        0
                                        • P Offline
                                          P Offline
                                          Pensionisten
                                          wrote on sidst redigeret af
                                          #707

                                          Måske nogle markedsdeltagere, der skal have justeret op til kvartalsskiftet - evt. shortere, der vil nedbringe/dækkes ind?

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper